Dilpacimab
Product Specifications
CAS Number
1791420-09-1
Target
VEGFR, Gamma-secretase
Related Pathways
Angiogenesis, Stem Cells, Neuroscience, Proteases/Proteasome, Tyrosine Kinase/Adaptors
Purity
0.977
Bioactivity
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin that simultaneously targets the delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) signaling pathways. Dilpacimab has significant potential in cancer research due to its dual targeting of tumor angiogenesis and Notch signaling.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6226932-01 0.1 mL
CDH2 (Cadherin 2, Type 1, N-Cadherin (Neuronal), CD325, CDHN, CDw325, NCAD) (MaxLight 650)
Sign In for Pricing
View Details MBS6226932-02 5x 0.1 mL
CDH2 (Cadherin 2, Type 1, N-Cadherin (Neuronal), CD325, CDHN, CDw325, NCAD) (MaxLight 650)
Sign In for Pricing
View Details 
T2750-04F 25 µg
Terminal Deoxynucleotidyl Transferase (TdT) (FITC) (Mixture of 4 Monoclonal Antibodies)
Sign In for Pricing
View Details